Solventum has four business segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. Solventum's MedSurg segment provides advanced wound care and surgical solutions. Solventum's Dental Solutions is a provider of a comprehensive suite of restorative, preventive, and orthodontic solutions for dentists and orthodontists. Solventum's Health Information Systems (HIS) segment provides software solutions powered by clinical intelligence that create time for clinicians to care for patients and improve accuracy in healthcare reimbursement. Target customer markets include public and private hospitals, physician groups, and clinics, federal government agencies and payer organizations. As noted earlier, Thermo Fisher has agreed to acquire the Purification and Filtration business, provides filters and membranes for use in the manufacturing of biopharmaceutical and medical technologies, microelectronics, and food and beverage products, as well as filtration for cleaner drinking water. SOLV is a component of the S&P 500 Index.

Stock indices are all broadly lower at midday on Friday, following significant loses yesterday. The major theme remains the serious uncertainty over tariffs and all tariff-related issues. That was the case a week ago as well -- but now that more is known about the actual tariffs, the issues have seemingly only grown. Indeed, investors are parsing the math and the logic behind the tariffs, the possible actual impact of the tariffs, and (now starting to come in) retaliatory actions from other countries. China got that ball rolling when it announced a host of countermeasures to U.S. tariffs. Meanwhile, the Bureau of Labor Statistics reported this morning that the U.S. economy generated 228,000 nonfarm jobs in March, well above the consensus of 135,000. While that relatively good news initially led to stock prices to being 'less red,' the impact has faded and was nowhere near enough to get the major indices to breakeven, let alone gains.

The Argus Research Fundamental Universe of Coverage includes more than 500 leading U.S. and international companies. We cover the waterfront -- from Information Technology to Utilities and from Energy to Healthcare. Generally, we follow the top 200 most widely held stocks, a list we source from our sister company Vickers Stock Research, which collects institutional ownership data from the U.S. Securities and Exchange Commission. From there, we look to identify the next 200-300 emerging U.S. and international companies for our coverage list. Our universe is dynamic and growing and we are continually adding stocks to coverage -- often based on great ideas from our clients. Here are some of our additions in 2024.

Solventum has four business segments: MedSurg, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum's MedSurg segment provides advanced wound care and surgical solutions. Customers include public and private health systems, ambulatory surgical centers, skilled nursing facilities and long-term care facilities. The addressable market for the company in this segment is approximately $26 billion and is growing at a 3%-5% rate. MedSurg's revenue has been flat over the past three years, with an average operating margin of approximately 23%. Solventum's Dental Solutions is a provider of a comprehensive suite of restorative, prevention and orthodontic solutions for dentists and orthodontists. The addressable market for the company in this segment is approximately $17 billion and is growing at a 4%-6% rate. Dental Solutions revenue has declined 5% over the past three years, and the average operating margin has been approximately 33%. Solventum's Health Information Systems (HIS) segment provides software solutions powered by clinical intelligence that create time for clinicians to care for patients and improve accuracy in healthcare reimbursement. Target customer markets include public and private hospitals, physician groups and clinics, federal government agencies and payer organizations. The addressable market for the company in this segment is approximately $9 billion and is growing at a 6%-8% rate. HIS revenue has risen 10% over the past three years, and the average operating margin has been approximately 31%. Solventum's Purification and Filtration segment provides filters and membranes for use in the manufacturing of biopharmaceutical and medical technologies, microelectronics and food and beverage products, as well as filtration for cleaner drinking water. Clients include biopharmaceutical and medical device manufacturers. The addressable market for the company in this segment is approximately $41 billion and is growing at a 4%-6% rate. PF revenue has declined 3% over the past three years, and the average operating margin has been approximately 18%. The company has 22,000 employees. SOLV is a component of the S&P 500 Index.